APRIL - 20226Managing EditorAlex D'souzaEditorial StaffVisualizerDavid JohnJaxon JaseSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Joshua Parker Merlin WatsonJoe Philip Laura PintoAPRIL 07 - 2022, volume 06 - Issue 04 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2022 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on our interviews with CIOs and CXOsAlex D'souzaManaging Editoreditor@medicaltechoutlook.comFor several years now, cardiovascular diseases (CVDs) have remained the leading cause of massive deaths globally. For a long time, though, it was believed that CVD occurred only in adults and the elderly. Today, there are rising numbers of untimely deaths in young adults due to heart-related diseases, indicating that CVDs are no longer age-biased. In the aftermath of the pandemic, the situation could be observed to worsen, where many recovered patients are suffering unexpected strokes and heart attacks. Considering only a small portion of CVD patients are able to undergo surgery, the mortality rate of heart-related problems still remains the highest among all other diseases. Thus it is evident that the global healthcare ecosystem must come together and develop solutions that render CVD patients a possibility to lead healthier and happier lives.In this edition of MedTech Outlook Europe, we present the list of the most successful and innovative cardiovascular devices companies in Europe. These companies are rendering highly optimized and customer-centric solutions and transforming the region's medtech market. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs presenting their ideas and opinions on why the mini-invasive surgical approach is a reasonable compromise for aortic and mitral valve repairment, how physical reality and digital technology are coming together to ensure to the efficient delivery of medical services, and more. We hope the valuable insights from industry thought leaders and the cutting-edge solutions from cardiovascular devices companies featured in this edition help you make informed decisions for your organization.Let us know your thoughts!Efficient Cardiovascular Devices for Improved CVD TreatmentsSarah FernandesEDITORIAL
< Page 5 | Page 7 >